Invesco Ltd. - MIRATI THERAPEUTICS INC ownership

MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 215 filers reported holding MIRATI THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.31 and the average weighting 0.7%.

Quarter-by-quarter ownership
Invesco Ltd. ownership history of MIRATI THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$2,616,563
-13.9%
60,068
-28.6%
0.00%0.0%
Q2 2023$3,037,522
-47.4%
84,072
-45.9%
0.00%
-50.0%
Q1 2023$5,776,248
-70.6%
155,359
-64.2%
0.00%
-66.7%
Q4 2022$19,645,329
-51.6%
433,576
-25.4%
0.01%
-53.8%
Q3 2022$40,570,000
+36.5%
580,908
+31.2%
0.01%
+44.4%
Q2 2022$29,719,000
-15.3%
442,712
+3.7%
0.01%0.0%
Q1 2022$35,107,000
-39.8%
426,989
+7.4%
0.01%
-35.7%
Q4 2021$58,297,000
-52.2%
397,413
-42.3%
0.01%
-54.8%
Q3 2021$121,876,000
+123.2%
688,914
+103.8%
0.03%
+138.5%
Q2 2021$54,613,000
-3.1%
338,096
+2.7%
0.01%
-13.3%
Q1 2021$56,389,000
-48.9%
329,180
-34.5%
0.02%
-53.1%
Q4 2020$110,395,000
+29.5%
502,616
-2.1%
0.03%
+10.3%
Q3 2020$85,220,000
+2636.7%
513,220
+1781.5%
0.03%
+2800.0%
Q2 2020$3,114,000
+32.7%
27,277
-10.7%
0.00%0.0%
Q1 2020$2,347,000
-96.1%
30,536
-93.4%
0.00%
-94.7%
Q4 2019$59,749,000
-6.6%
463,670
-43.5%
0.02%
+11.8%
Q3 2019$63,969,000
-38.1%
821,056
-18.1%
0.02%
-37.0%
Q2 2019$103,288,000
+503.8%
1,002,795
+329.7%
0.03%
+350.0%
Q1 2019$17,106,000
+217.0%
233,366
+83.4%
0.01%
+200.0%
Q4 2018$5,397,000
-67.6%
127,236
-64.0%
0.00%
-60.0%
Q3 2018$16,651,000
+33.0%
353,531
+39.2%
0.01%
+25.0%
Q2 2018$12,519,000
+208550.0%
253,941
+145009.1%
0.00%
Q2 2015$6,0001750.00%
Other shareholders
MIRATI THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Aviva Holdings Ltd. 2,881,702$14,985,0006.99%
Avoro Capital Advisors LLC 2,383,201$12,393,0001.58%
Broadfin Capital, LLC 2,090,801$10,872,0001.32%
Boxer Capital, LLC 1,037,994$5,398,0001.18%
Ghost Tree Capital, LLC 172,184$895,0000.17%
Baker Brothers Advisors 2,269,198$11,800,0000.10%
Hillhouse Capital Management 725,000$3,770,0000.07%
SABBY MANAGEMENT, LLC 249,735$1,299,0000.07%
Rhenman & Partners Asset Management AB 50,000$260,0000.04%
Trexquant Investment LP 42,879$223,0000.03%
View complete list of MIRATI THERAPEUTICS INC shareholders